Fumiyoshi Ohyanagi

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer

Rie Sakakibara, Kentaro Inamura, Yuichi Tambo et al. · Clinical Lung Cancer · 2016 · 130 citations

Medicine, Cancer Biology, Oncology +11

Detection of Epidermal Growth Factor Receptor Mutation in Transbronchial Needle Aspirates of Non-Small Cell Lung Cancer

Atsushi Horiike, Hideharu Kimura, Kazuto Nishio et al. · CHEST Journal · 2007 · 98 citations

Medicine, Oncology, Pathology +12

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

K. Suzuki, Takeharu Yamanaka, Hiroki Hashimoto et al. · Annals of Oncology · 2016 · 97 citations · Full text

Medicine, Oncology, Pharmacology +16

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

Akihiko Shimomura, Noboru Yamamoto, Shunsuke Kondo et al. · Molecular Cancer Therapeutics · 2019 · 90 citations

Medicine, Pharmacokinetics, Pharmacology +8

Detection of epidermal growth factor receptor T790M mutation in plasma <scp>DNA</scp> from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor

Kazuko Sakai, Atsushi Horiike, Darryl Irwin et al. · Cancer Science · 2013 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17